GRIP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63091762317435E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62680979798324E-12 |
Normal-vs-Stage2 |
3.83179999999816E-05 |
Normal-vs-Stage3 |
1.62581059726108E-12 |
Normal-vs-Stage4 |
1.87627691161651E-14 |
Stage1-vs-Stage2 |
1.662760E-01 |
Stage1-vs-Stage3 |
6.365200E-01 |
Stage1-vs-Stage4 |
5.078600E-01 |
Stage2-vs-Stage3 |
1.345960E-01 |
Stage2-vs-Stage4 |
2.511800E-01 |
Stage3-vs-Stage4 |
3.381800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62747593179802E-12 |
Normal-vs-AfricanAmerican |
9.77029568360877E-11 |
Normal-vs-Asian |
8.055300E-03 |
Caucasian-vs-AfricanAmerican |
1.572830E-01 |
Caucasian-vs-Asian |
3.927600E-01 |
AfricanAmerican-vs-Asian |
8.009200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62836411021772E-12 |
Normal-vs-Female |
1.62458935193399E-12 |
Male-vs-Female |
6.168400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.1094237467878E-15 |
Normal-vs-Age(41-60Yrs) |
3.76365605347928E-14 |
Normal-vs-Age(61-80Yrs) |
1.63102864547682E-12 |
Normal-vs-Age(81-100Yrs) |
1.62503344114384E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.404000E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.130250E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.979000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.327600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.531700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.373800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.63578048276258E-12 |
Normal-vs-Grade 2 |
9.99200722162641E-16 |
Normal-vs-Grade 3 |
1.64723790163634E-12 |
Normal-vs-Grade 4 |
1.62536650805123E-12 |
Grade 1-vs-Grade 2 |
5.140600E-01 |
Grade 1-vs-Grade 3 |
1.102960E-01 |
Grade 1-vs-Grade 4 |
5.263600E-01 |
Grade 2-vs-Grade 3 |
9.135600E-02 |
Grade 2-vs-Grade 4 |
8.623800E-01 |
Grade 3-vs-Grade 4 |
1.166780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.11022302462516E-16 |
Normal-vs-ccB subtype |
1.70441438740454E-12 |
ccA subtype-vs-ccB subtype |
1.777790E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.38475905689484E-13 |
Normal-vs-N1 |
1.09469999731715E-08 |
N0-vs-N1 |
8.683600E-01 |
|
|